address the attached reviewer‘s commentaddress是什么意思思

高手帮我看看编辑是什么意思_百度知道关注今日:96 | 主题:508124
微信扫一扫
扫一扫,下载丁香园 App
即送15丁当
【经验】撰写与发表SCI论文有问必答专帖(附有关资料及模版链接)&[精华]
页码直达:
solopower our Letter to the Editor has been published发件人:European Heart Journal Rapid Response
时 间:日(星期五) 上午8:05 (UTC-07:00 休斯顿、底特律时间) 收件人:XXXX抄 送:jnls.eprod ; ehj-letter.DIM Dear XXXYour E-letter to the Editor has been published on The Journal's web site:. You may view it by clicking on the &E-letters& link on the home page and then clicking on &Read recently published Letters&. Scroll down to see your letter. Alternatively, you may go to the 'Full Text' of the article to which you referred in your letter and click on &View Responses& in the right panel.Your Letter: &XXXXXX&Letter URL: Your E-letter has provided a forum for readers and authors to have an ongoing dialogue about the ultimate impact of this information. The Journal is most appreciative of your effort.Sincerely,Editor European Heart Journal链接一直打不开。 10号夜里收到的邮件。我有没有必要写信给编辑问问?我也试了,打开了以后显示如下:,可以发信问问。 Page Not Found
The requested page &lookup/eletters/ehu283v2& could not be found.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
直接回复ehj-feedback@highwire.stanford.edu,还是去网上查编辑?投稿当天的回信: Thank you for your E-letter to European Heart Journal发件人:European Heart Journal Rapid Response
间:日(星期二) 上午9:55 (UTC-07:00 休斯顿、底特律时间)收件人:XXX抄
送:jnls.eprod ; ehj-letter.DIM
DearXXX,Thank you for your submission. Below is a copy of your letter as wereceived it. Your letter, if accepted, should be viewable within a few days time.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
solopower edited on
solopower 直接回复ehj-feedback@highwire.stanford.edu,还是去网上查编辑?投稿当天的回信: Thank you for your E-letter to European Heart Journal发件人:European Heart Journal Rapid Response
间:日(星期二) 上午9:55 (UTC-07:00 休斯顿、底特律时间) 收件人:XXX抄
送:jnls.eprod ; ehj-letter.DIM
DearXXX,Thank you for your submission. Below is a copy of your letter as wereceived it. Your letter, if accepted, should be viewable within a few days time. 可以直接回复此邮件
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
谢谢。我这篇letter正是一点之见成的文。园里有同志告诉我是估计与EHJ最近网站改版有关系吧,要不就是还没发出来。确实网站其他letters也打不开。过几天还没有我就发信问问。再次感谢。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请教老师,molecular medicine reports, expermantical and therapeutic medicine, Pain这3个杂志是否接受case reports?谢谢回答
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
5721268 请教老师,molecular medicine reports, expermantical and therapeutic medicine, Pain这3个杂志是否接受case reports?谢谢回答Experimental and therapeutic medicine杂志接受发表case report类型文章比较多。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请教老师, 我的一篇Elsevier旗下文章14号收到proof,15号提交回去,杂志社的网页In press 里面写available online Oct.15,可现在在pubmed 和SCI数据库都查不到,我急需开检索证明,可以催编辑一下,还是只能等待了那
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
心脏冠脉介入方面低分SCI,主要是操作技巧的小观点,这方面的杂志有哪些好发表。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
乐赢赢 请教老师, 我的一篇Elsevier旗下文章14号收到proof,15号提交回去,杂志社的网页In press 里面写available online Oct.15,可现在在pubmed 和SCI数据库都查不到,我急需开检索证明,可以催编辑一下,还是只能等待了那 需要等待,催没有用
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
jxxinglin 你好:
心脏冠脉介入方面低分SCI,主要是操作技巧的小观点,这方面的杂志有哪些好发表。 请参考附件中的杂志列表。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
老师您好!2天前在urologia internationalis投了篇文章,投完后,收到了自动回复邮件,但系统里没有查询稿件状态的选项,这是为什么?
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
yxl_lxy 老师您好!2天前在urologia internationalis投了篇文章,投完后,收到了自动回复邮件,但系统里没有查询稿件状态的选项,这是为什么? 若收到的确实是投稿成功的邮件的话,那就不用这么担心。过几天再查查,看是否一样。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请问老师,告知老外310英镑版面费已转账,请查收,可以这样说吗。We are pleased to inform you that a credit transfer, GBP f 310, has been made to your account. Attached is the cash remittance from the bank, please check it.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
5721268 请问老师,告知老外310英镑版面费已转账,请查收,可以这样说吗。We are pleased to inform you that a credit transfer, GBP f 310, has been made to your account. Attached is the cash remittance from the bank, please check it. 修改如下: We are pleased to inform you that we have paid the page charge, GBP f 310, to your designated account.
Attached is the transaction record from the bank, please check it.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
老师你好,我有一篇case report,准备投Elsevier旗下的一个杂志,但是在投稿过程中要求提供伦理问题的IBR号或者相关证明,不清楚该怎么弄?如果写没有会怎么样?能否详细指导一下,谢谢!
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请问老师, 申请plos one减免出版费,老外提的grant documents and remaining grant balances, bank statements是什么意思?必须都提供吗?Greetings Dr. Liu,Thank you for your message. Our program is chartered to provide financial assistance to those with demonstrated need.Can you please provide supporting financial documents (e.g. grant documents and remaining grant balances, bank statements) to help us determine your financial assistance? Without financial documents, we can only extend you a 20% fee waiver. Please note that upon receipt of documents, we will review and grant financial assistance based on our available budget.Please advise if you will provide additional information or if you will accept a 20% fee waiver. Thanks and Regards,Susan Au
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
mmp0128 老师你好,我有一篇case report,准备投Elsevier旗下的一个杂志,但是在投稿过程中要求提供伦理问题的IBR号或者相关证明,不清楚该怎么弄?如果写没有会怎么样?能否详细指导一下,谢谢! 提供你所在单位伦理委员会的批准证明。具体不了解不提供此证明的后果
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
老师,我有一篇文章在美捷登老师们的帮助下投到了plos one,大修以后今天收到回复,请老师帮忙看看,不知道是接受了还是怎么了。当前状态是Decision in Process。邮件内容如下:PONE-D-14-24606R1After careful consideration, we are pleased to inform you that your manuscript will likely be suitable for publication once it meets the journal's final technical requirements.Before your submission can be formally accepted and proceed to production, you will need to address all formatting changes as requested. These required modifications will be provided in a follow-up e-mail that you will receive within one week. Your manuscript will not be scheduled for publication until you have made these required changes.In the meantime, please log into Editorial Manager at
click the &Update My Information& link at the top of the page, and update your user information to ensure an efficient production and billing process.With kind regards,Michael Scheurer, Ph.D.Academic EditorPLOS ONEReviewers' comments:Reviewer's Responses to QuestionsComments to the Author1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your &Accept& recommendation.Reviewer #1: All comments have been addressed--------------------2. Is the manuscript technically sound, and do the data support the conclusions?The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes--------------------3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know--------------------4. Does the manuscript adhere to the PLOS Data Policy?Authors must follow the , which requires authors to make all data underlying the findings described in their manuscript fully available without restriction. Please refer to the author’s Data Availability Statement in the manuscript. All data and related metadata must be deposited in an appropriate public repository, unless already provided as part of the submitted article or supporting information. If there are restrictions on the ability of authors to publicly share data—e.g. privacy or use of data from a third party— these reasons must be specified.Reviewer #1: Yes--------------------5. Is the manuscript presented in an intelligible fashion and written in standard English?PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.Reviewer #1: Yes--------------------6. Review Comments to the AuthorPlease use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)Reviewer #1: This revision has significantly improved the quality of the paper. Though as the authors also indicate, the biological significance of this study needs to be further substantiated in the future.--------------------7. If you would like your identity to be revealed to the authors, please include your name here (optional).Your name and review will not be published with the manuscript. Reviewer #1: (No Response)但是我不是很了解的是当前状态是decision in progress,有点迷惑。谢谢老师解答
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
5721268 请问老师, 申请plos one减免出版费,老外提的grant documents and remaining grant balances, bank statements是什么意思?必须都提供吗?Greetings Dr. Liu,Thank you for your message. Our program is chartered to provide financial assistance to those with demonstrated need.Can you please provide supporting financial documents (e.g. grant documents and remaining grant balances, bank statements) to help us determine your financial assistance? Without financial documents, we can only extend you a 20% fee waiver. Please note that upon receipt of documents, we will review and grant financial assistance based on our available budget.Please advise if you will provide additional information or if you will accept a 20% fee waiver. Thanks and Regards,Susan Au让提供基金信息,及余额等等。不提供应该不会考虑减免
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
cannine 老师,我有一篇文章在美捷登老师们的帮助下投到了plos one,大修以后今天收到回复,请老师帮忙看看,不知道是接受了还是怎么了。当前状态是Decision in Process。邮件内容如下:PONE-D-14-24606R1After careful consideration, we are pleased to inform you that your manuscript will likely be suitable for publication once it meets the journal's final technical requirements.Before your submission can be formally accepted and proceed to production, you will need to address all formatting changes as requested. These required modifications will be provided in a follow-up e-mail that you will receive within one week. Your manuscript will not be scheduled for publication until you have made these required changes.In the meantime, please log into Editorial Manager at
click the &Update My Information& link at the top of the page, and update your user information to ensure an efficient production and billing process.With kind regards,Michael Scheurer, Ph.D.Academic EditorPLOS ONEReviewers' comments:Reviewer's Responses to QuestionsComments to the Author1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your &Accept& recommendation.Reviewer #1: All comments have been addressed--------------------2. Is the manuscript technically sound, and do the data support the conclusions?The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes--------------------3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know--------------------4. Does the manuscript adhere to the PLOS Data Policy?Authors must follow the , which requires authors to make all data underlying the findings described in their manuscript fully available without restriction. Please refer to the author’s Data Availability Statement in the manuscript. All data and related metadata must be deposited in an appropriate public repository, unless already provided as part of the submitted article or supporting information. If there are restrictions on the ability of authors to publicly share data—e.g. privacy or use of data from a third party— these reasons must be specified.Reviewer #1: Yes--------------------5. Is the manuscript presented in an intelligible fashion and written in standard English?PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.Reviewer #1: Yes--------------------6. Review Comments to the AuthorPlease use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)Reviewer #1: This revision has significantly improved the quality of the paper. Though as the authors also indicate, the biological significance of this study needs to be further substantiated in the future.--------------------7. If you would like your identity to be revealed to the authors, please include your name here (optional).Your name and review will not be published with the manuscript. Reviewer #1: (No Response)但是我不是很了解的是当前状态是decision in progress,有点迷惑。谢谢老师解答 基本上算是接受,还有格式方面需要修改,杂志社会把需要修改的地方发给你。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
敬请老师修改!Plos OneRe: PONE-D-13-46026R2: XXXXXDear Dr. Au,Thank you for your email. We really appreciate you taking the time to see our application letter of fee waiver.Our project is funded by the Science and Technology Project of Xuzhou city (Financial Allocation is RMB 15,000 or approx. $2,400), please see the financial documents we provide (Appendix 1: no.XM13B084, temozolomide loaded nano delivery system combined with adenovirus for the targeted therapy of melanoma). As we all know, nanomaterials is very expensive (please refer to Appendix 2). So we could just mange to conduct and complete our experiments with these funds.However, it is our honor that the article can be published in your journal. If there is a difficulty to offer such a concession, we will make our every effort to accept a 20% fee wavier.Thank very much for your consideration, and look forward to hearing from you soon.With kind regards,Yours sincerely,XXXX,
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园中级站友
5721268 敬请老师修改!Plos OneRe: PONE-D-13-46026R2: XXXXXDear Dr. Au,Thank you for your email. We really appreciate you taking the time to see our application letter of fee waiver.Our project is funded by the Science and Technology Project of Xuzhou city (Financial Allocation is RMB 15,000 or approx. $2,400), please see the financial documents we provide (Appendix 1: no.XM13B084, temozolomide loaded nano delivery system combined with adenovirus for the targeted therapy of melanoma). As we all know, nanomaterials is very expensive (please refer to Appendix 2). So we could just mange to conduct and complete our experiments with these funds.However, it is our honor that the article can be published in your journal. If there is a difficulty to offer such a concession, we will make our every effort to accept a 20% fee wavier.Thank very much for your consideration, and look forward to hearing from you soon.With kind regards,Yours sincerely,XXXX,
Ph.DI already replied to you by email.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
楼主您好,请问 这个期刊怎么样,已经被SCI收录,杂志口碑如何?接受国人文章多吗,好发表吗?谢谢。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
桃花岛2012 楼主您好,请问 这个期刊怎么样,已经被SCI收录,杂志口碑如何?接受国人文章多吗,好发表吗?谢谢。 和其它开放获取期刊一样,值得一试。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
你好,我想咨询下关于文章许可的问题。我这上面的几个基金都没有,那么我下面6个该怎么选,不是很理解者6个选项的意义。谢谢
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
有请老师赐教。Dr. Spandidos, It has been 2 weeks since we paid Payment for the manuscript entitled “A novel oncolytic adenovirus sensitizes renal cell carcinoma cells to radiotherapy via mitochondrial apoptotic cell death” (MS No.: MMR-) to your designated account, but I have not heard from you yet. Thus, I am writing you to ask if you have received Payment for the manuscript (MS No.: MMR-). Thanks!
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wusj120 你好,我想咨询下关于文章许可的问题。我这上面的几个基金都没有,那么我下面6个该怎么选,不是很理解者6个选项的意义。谢谢根据如上描述,应该是选择2
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
老师您好,慕名前来我的第一篇SCI最近返修了,是大修,两位审稿人意见不一,第二位基本没有问题,第一位认为文章不错,但与该杂志内容范围不太符,觉得需要补充我这个量表与其它量表相比优势的相关数据与内容,而编辑好像也站在他这边。但我这篇文章的立意就是检测这个量表在中国人群的适用度,其它相似文章也是这么写的,而与其它量表对比又是另一类型的文章了。现在在这想请问一下,我是否可以按照第一位审稿人说的补充部分数据(最多一个表格,因数据不足,只能简略对比一下我的量表和其它量表的信度,而效度、反应度等其它很多指标没办法做出来),在文中的introduction和discussion部分我再另辟两个小段叙述下这个量表的优点,如此修改不知是否符合返修意见以及能否让编辑满意?还是需要对整个文章的结构及讨论的重心进行彻底修改?(我现在内容重心主要在该量表在中国人群的各种指标检测,而其与其它量表的孰优孰劣基本未涉及,只是在introduction中简略叙述了其优点)。希望老师能给一些意见,非常感谢!下面是相关审稿意见:Comments from Editors:In general this study could be important for Chinese people. However we believe that most of Modern Reumatology readers Do not appreciate the value of this study at present form. So we believe that the author should state clearly the difference from the established QOL questionnaire for hip and knee. Reviewers' comments:Reviewer #1: Over all, it is well written.
The point is whether if the current manuscript meets the scope of Modern Rheumatology. This is a definitely valuable study for Chinese health professionals and patients. Please consider some additional analysis to provide information which is applicable for general readers.
For example, show the superiority of OAKHQOL to other scales for some purpose.
Reviewer #2: Reviewer's reportWang et al. have developed a valid simplified Chinese version of the Osteoarthritis of Knee and Hip Quality of Life questionnaire. This is an interesting manuscript. Page 8: The reviewer is unable to understand the meaning of the phrase &duration of knee of hip OA was …& Please clarify what it means.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请问接收头颈肿瘤方面的综述的杂志有哪些?IF值不限。谢谢!
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
老师,最近编辑把稿件退回来了,说是
Be sure to use a structured abstract, with headings. Use the specific headings listed in the guidelines checklist if your report is based on the CARE, CHEERS, CONSORT, or PRISMA guidelines.
我的是一篇诊断试验,用应该是STARD guideline。 他上面的意见是什么意思?是说我摘要没有结构?我摘要是分四段,按aim method result conclusion来写的,就是每段前面没加这几个小标题。我琢磨不透编辑的意思,投的是《medicine》这个杂志。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请教老师,下面的来信可以看做是让文章回修,还是只是编辑部内部审,还没送到审稿人手里?“Write review objectively in explicit fashion.”是什么意思? Dear Dr. Jiang,The editor has studied your subject manuscript for consideration of publication. His comments are given below:Comments of Editor:Write review objectively in explicit fashion. Define search strategy (year of search, database search inclusion/exclusion criteria etc). Forwarded as above.
With best wishesSincerely yours,Muhammad Zafaruddin
Executive Editor
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
as5235 老师您好,慕名前来我的第一篇SCI最近返修了,是大修,两位审稿人意见不一,第二位基本没有问题,第一位认为文章不错,但与该杂志内容范围不太符,觉得需要补充我这个量表与其它量表相比优势的相关数据与内容,而编辑好像也站在他这边。但我这篇文章的立意就是检测这个量表在中国人群的适用度,其它相似文章也是这么写的,而与其它量表对比又是另一类型的文章了。现在在这想请问一下,我是否可以按照第一位审稿人说的补充部分数据(最多一个表格,因数据不足,只能简略对比一下我的量表和其它量表的信度,而效度、反应度等其它很多指标没办法做出来),在文中的introduction和discussion部分我再另辟两个小段叙述下这个量表的优点,如此修改不知是否符合返修意见以及能否让编辑满意?还是需要对整个文章的结构及讨论的重心进行彻底修改?(我现在内容重心主要在该量表在中国人群的各种指标检测,而其与其它量表的孰优孰劣基本未涉及,只是在introduction中简略叙述了其优点)。希望老师能给一些意见,非常感谢!下面是相关审稿意见:Comments from Editors:In general this study could be important for Chinese people. However we believe that most of Modern Reumatology readers Do not appreciate the value of this study at present form. So we believe that the author should state clearly the difference from the established QOL questionnaire for hip and knee. Reviewers' comments:Reviewer #1: Over all, it is well written.
The point is whether if the current manuscript meets the scope of Modern Rheumatology. This is a definitely valuable study for Chinese health professionals and patients. Please consider some additional analysis to provide information which is applicable for general readers.
For example, show the superiority of OAKHQOL to other scales for some purpose.
Reviewer #2: Reviewer's reportWang et al. have developed a valid simplified Chinese version of the Osteoarthritis of Knee and Hip Quality of Life questionnaire. This is an interesting manuscript. Page 8: The reviewer is unable to understand the meaning of the phrase &duration of knee of hip OA was …& Please clarify what it means.我是否可以按照第一位审稿人说的补充部分数据(最多一个表格,因数据不足,只能简略对比一下我的量表和其它量表的信度,而效度、反应度等其它很多指标没办法做出来),在文中的introduction和discussion部分我再另辟两个小段叙述下这个量表的优点,如此修改不知是否符合返修意见以及能否让编辑满意? ----这样做就可以了。既显得最终他的建议,又对文章进行了修改。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
tiancailiba 请问接收头颈肿瘤方面的综述的杂志有哪些?IF值不限。谢谢!请参考如下链接附件中的list
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
wusj120 老师,最近编辑把稿件退回来了,说是
Be sure to use a structured abstract, with headings. Use the specific headings listed in the guidelines checklist if your report is based on the CARE, CHEERS, CONSORT, or PRISMA guidelines.
我的是一篇诊断试验,用应该是STARD guideline。 他上面的意见是什么意思?是说我摘要没有结构?我摘要是分四段,按aim method result conclusion来写的,就是每段前面没加这几个小标题。我琢磨不透编辑的意思,投的是《medicine》这个杂志。摘要中是需要加上小标题。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
5721268 请教老师,下面的来信可以看做是让文章回修,还是只是编辑部内部审,还没送到审稿人手里?“Write review objectively in explicit fashion.”是什么意思? Dear Dr. Jiang,The editor has studied your subject manuscript for consideration of publication. His comments are given below:Comments of Editor:Write review objectively in explicit fashion. Define search strategy (year of search, database search inclusion/exclusion criteria etc). Forwarded as above.
With best wishesSincerely yours,Muhammad Zafaruddin
Executive Editor杂志社内部审的,编辑审完后有问题,比如让你用更客观明确地方式来写。另外就是界定你搜索或查新标准。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
关于丁香园

我要回帖

更多关于 comments是什么意思 的文章

 

随机推荐